2127 related articles for article (PubMed ID: 8586465)
21. Cloning and characterization of a mouse gene with homology to the human von Hippel-Lindau disease tumor suppressor gene: implications for the potential organization of the human von Hippel-Lindau disease gene.
Gao J; Naglich JG; Laidlaw J; Whaley JM; Seizinger BR; Kley N
Cancer Res; 1995 Feb; 55(4):743-7. PubMed ID: 7850784
[TBL] [Abstract][Full Text] [Related]
22. Mutations in transcript isoforms of the neurofibromatosis 2 gene in multiple human tumour types.
Bianchi AB; Hara T; Ramesh V; Gao J; Klein-Szanto AJ; Morin F; Menon AG; Trofatter JA; Gusella JF; Seizinger BR
Nat Genet; 1994 Feb; 6(2):185-92. PubMed ID: 8162073
[TBL] [Abstract][Full Text] [Related]
23. Frequent allelic loss at chromosome arm 3p is distinct from genetic alterations of the Von-Hippel Lindau tumor suppressor gene in head and neck cancer.
Waber PG; Lee NK; Nisen PD
Oncogene; 1996 Jan; 12(2):365-9. PubMed ID: 8570213
[TBL] [Abstract][Full Text] [Related]
24. Neurofibromatosis type 2: a new mechanism of tumor suppression.
Lutchman M; Rouleau GA
Trends Neurosci; 1996 Sep; 19(9):373-7. PubMed ID: 8873351
[TBL] [Abstract][Full Text] [Related]
25. Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma.
Seizinger BR; Rouleau GA; Ozelius LJ; Lane AH; Farmer GE; Lamiell JM; Haines J; Yuen JW; Collins D; Majoor-Krakauer D
Nature; 1988 Mar; 332(6161):268-9. PubMed ID: 2894613
[TBL] [Abstract][Full Text] [Related]
26. Chromosome 3p deletion in a renal cell carcinoma cell line established from a patient with von Hippel-Lindau disease.
Kohno T; Sekine T; Tobisu K; Oshimura M; Yokota J
Jpn J Clin Oncol; 1993 Aug; 23(4):226-31. PubMed ID: 8105119
[TBL] [Abstract][Full Text] [Related]
27. Genetic analysis of von Hippel-Lindau disease.
Nordstrom-O'Brien M; van der Luijt RB; van Rooijen E; van den Ouweland AM; Majoor-Krakauer DF; Lolkema MP; van Brussel A; Voest EE; Giles RH
Hum Mutat; 2010 May; 31(5):521-37. PubMed ID: 20151405
[TBL] [Abstract][Full Text] [Related]
28. [von Hippel-Lindau hereditary tumor syndrome. Mutational analysis may improve prognosis].
Wiklund L; Nordling M; Engwall Y; Martinsson T; Szentgyörgyi E; Wahlström J
Lakartidningen; 1995 Mar; 92(11):1093-6. PubMed ID: 7700111
[TBL] [Abstract][Full Text] [Related]
29. Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma.
Whaley JM; Naglich J; Gelbert L; Hsia YE; Lamiell JM; Green JS; Collins D; Neumann HP; Laidlaw J; Li FP
Am J Hum Genet; 1994 Dec; 55(6):1092-102. PubMed ID: 7977367
[TBL] [Abstract][Full Text] [Related]
30. Identification of the promoter of the human von Hippel-Lindau disease tumor suppressor gene.
Kuzmin I; Duh FM; Latif F; Geil L; Zbar B; Lerman MI
Oncogene; 1995 Jun; 10(11):2185-94. PubMed ID: 7784063
[TBL] [Abstract][Full Text] [Related]
31. Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines.
Sekido Y; Bader S; Latif F; Gnarra JR; Gazdar AF; Linehan WM; Zbar B; Lerman MI; Minna JD
Oncogene; 1994 Jun; 9(6):1599-604. PubMed ID: 8183553
[TBL] [Abstract][Full Text] [Related]
32. Copy number profiling in von Hippel-Lindau disease renal cell carcinoma.
Shuib S; Wei W; Sur H; Morris MR; McMullan D; Rattenberry E; Meyer E; Maxwell PH; Kishida T; Yao M; Latif F; Maher ER
Genes Chromosomes Cancer; 2011 Jul; 50(7):479-88. PubMed ID: 21456047
[TBL] [Abstract][Full Text] [Related]
33. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.
Hadfield KD; Smith MJ; Urquhart JE; Wallace AJ; Bowers NL; King AT; Rutherford SA; Trump D; Newman WG; Evans DG
Oncogene; 2010 Nov; 29(47):6216-21. PubMed ID: 20729918
[TBL] [Abstract][Full Text] [Related]
34. [Tumor suppressor gen mutation in the germ line: its significance in familial and sporadic tumors].
Müller H; Scott RJ
Schweiz Med Wochenschr; 1995 Jul; 125(30):1445-54. PubMed ID: 7676234
[TBL] [Abstract][Full Text] [Related]
35. Neurofibromatosis type 2: molecular and clinical analyses in Argentine sporadic and familial cases.
Ferrer M; Schulze A; Gonzalez S; Ferreiro V; Ciavarelli P; Otero J; Giliberto F; Basso A; Szijan I
Neurosci Lett; 2010 Aug; 480(1):49-54. PubMed ID: 20553997
[TBL] [Abstract][Full Text] [Related]
36. A deletion mutation of the VHL gene associated with a patient with sporadic von Hippel-Lindau disease.
Jia D; Tang B; Shi Y; Wang J; Sun Z; Chen Z; Zhang L; Xia K; Jiang H
J Clin Neurosci; 2013 Jun; 20(6):842-7. PubMed ID: 23632291
[TBL] [Abstract][Full Text] [Related]
37. Frequent NF2 gene transcript mutations in sporadic meningiomas and vestibular schwannomas.
Lekanne Deprez RH; Bianchi AB; Groen NA; Seizinger BR; Hagemeijer A; van Drunen E; Bootsma D; Koper JW; Avezaat CJ; Kley N
Am J Hum Genet; 1994 Jun; 54(6):1022-9. PubMed ID: 7911002
[TBL] [Abstract][Full Text] [Related]
38. Analysis of von hippel-lindau mutations with comparative genomic hybridization in sporadic and hereditary hemangioblastomas: possible genetic heterogeneity.
Gijtenbeek JM; Jacobs B; Sprenger SH; Eleveld MJ; van Kessel AG; Kros JM; Sciot R; van Calenbergh F; Wesseling P; Jeuken JW
J Neurosurg; 2002 Oct; 97(4):977-82. PubMed ID: 12405390
[TBL] [Abstract][Full Text] [Related]
39. Genetic flanking markers refine diagnostic criteria and provide insights into the genetics of Von Hippel Lindau disease.
Seizinger BR; Smith DI; Filling-Katz MR; Neumann H; Green JS; Choyke PL; Anderson KM; Freiman RN; Klauck SM; Whaley J
Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2864-8. PubMed ID: 2011596
[TBL] [Abstract][Full Text] [Related]
40. [Genetics of neurofibromatosis: recent progress and prospects].
Maillet-Vioud M; Narod S; Assouline D; Sobol H; Fischer G; Robert JM; Lenoir GM
Rev Neurol (Paris); 1991; 147(10):644-52. PubMed ID: 1763253
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
